EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+29.65%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.58B
AUM Growth
+$264M
(+20%)
Cap. Flow
-$55.8M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24
Top Buys
| 1 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
$3.5M |
| 2 |
Weibo
WB
|
$2.6M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$1.88M |
| 4 |
Deckers Outdoor
DECK
|
$1.72M |
| 5 |
Invesco QQQ Trust
QQQ
|
$1.55M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
$20.3M |
| 2 |
Yum China
YUMC
|
$12.8M |
| 3 |
Pinduoduo
PDD
|
$10.6M |
| 4 |
TSMC
TSM
|
$9.64M |
| 5 |
Apple
AAPL
|
$4.98M |
Sector Composition
| 1 | Consumer Discretionary | 50.26% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 8.85% |
| 4 | Real Estate | 5.2% |
| 5 | Healthcare | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
126
DELISTED
Blueprint Medicines
BPMC
| $599K | 0.04% |
6,493
-2,072
| -24% | -$191K |
|
127
Camtek
CAMT
$3.6B
| $599K | 0.04% |
+8,627
| New | +$599K |
|
128
Arrowhead Research
ARWR
$4.02B
| $598K | 0.04% |
19,531
+4,238
| +28% | +$130K |
|
129
BridgeBio Pharma
BBIO
$10.2B
| $596K | 0.04% |
14,769
-1,326
| -8% | -$53.5K |
|
130
Airbnb
ABNB
$75.8B
| $593K | 0.04% |
4,354
-334
| -7% | -$45.5K |
|
131
CRISPR Therapeutics
CRSP
$4.99B
| $592K | 0.04% |
9,460
+303
| +3% | +$19K |
|
132
Merck
MRK
$212B
| $587K | 0.04% |
5,388
+616
| +13% | +$67.2K |
|
133
Monster Beverage
MNST
$61B
| $574K | 0.04% |
9,960
-1,082
| -10% | -$62.3K |
|
134
Ultragenyx Pharmaceutical
RARE
$3.07B
| $568K | 0.04% |
11,871
+2,467
| +26% | +$118K |
|
135
Akero Therapeutics
AKRO
$3.58B
| $564K | 0.04% |
24,172
+14,744
| +156% | +$344K |
|
136
Revolution Medicines
RVMD
$7.57B
| $560K | 0.04% |
19,532
+7,877
| +68% | +$226K |
|
137
O'Reilly Automotive
ORLY
$89B
| $560K | 0.04% |
8,835
-1,125
| -11% | -$71.3K |
|
138
Krystal Biotech
KRYS
$4.35B
| $558K | 0.04% |
4,495
+808
| +22% | +$100K |
|
139
Exact Sciences
EXAS
$10.2B
| $549K | 0.03% |
7,421
+1,583
| +27% | +$117K |
|
140
Roivant Sciences
ROIV
$8.82B
| $549K | 0.03% |
48,860
+12,569
| +35% | +$141K |
|
141
Charter Communications
CHTR
$35.7B
| $548K | 0.03% |
1,409
-163
| -10% | -$63.4K |
|
142
Home Depot
HD
$417B
| $547K | 0.03% |
1,577
+8
| +0.5% | +$2.77K |
|
143
Baidu
BIDU
$35.1B
| $545K | 0.03% |
4,578
| – | – |
|
144
Procter & Gamble
PG
$375B
| $544K | 0.03% |
3,715
+36
| +1% | +$5.28K |
|
145
Iovance Biotherapeutics
IOVA
$901M
| $543K | 0.03% |
66,738
-10,112
| -13% | -$82.2K |
|
|
ANSS
146
DELISTED
Ansys
ANSS
| $540K | 0.03% |
1,489
-119
| -7% | -$43.2K |
|
147
Neurocrine Biosciences
NBIX
$14.3B
| $540K | 0.03% |
4,096
-89
| -2% | -$11.7K |
|
148
Madrigal Pharmaceuticals
MDGL
$9.65B
| $534K | 0.03% |
2,306
-21
| -0.9% | -$4.86K |
|
149
Recursion Pharmaceuticals
RXRX
$2.01B
| $533K | 0.03% |
54,094
-2,638
| -5% | -$26K |
|
150
Insmed
INSM
$30.7B
| $532K | 0.03% |
17,178
+3,130
| +22% | +$97K |
|